|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.30 USD | +1.99% |
|
-9.65% | -27.20% |
| 07-17 | EyePoint Pharmaceuticals Agrees to Settle US False Claims Act Allegations | MT |
| 07-16 | Stifel Initiates EyePoint Pharmaceuticals at Buy With $40 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 14.84 | 18.34 | 18.29 |
| Spread/Res. | -10.38% | -27.48% | -27.28% |
| Spread/Supp. | +16.16% | +16.16% | +18.64% |
| Support | 11.45 | 11.45 | 11.21 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- EYPT Stock
- Charts EyePoint, Inc.
Select your edition
All financial news and data tailored to specific country editions
